Driver gene alterations profiling of Chinese non‐small cell lung cancer and the effects of co‐occurring alterations on immunotherapy

BACKGROUND: Molecular testing for alterations in oncogenic driver genes and targeted therapies have become standard procedures for non‐small cell lung cancer (NSCLC) patients. However, little evidence has shed light on the pattern of co‐existence of driver genes in NSCLC, and whether they may have d...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Shengjie, Du, Wenjuan, Sun, Qiong, Zhao, Xiao, Qin, Boyu, Shi, Duozhi, Wan, Chong, Wu, Zhiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Bioinformatics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525092/
https://www.ncbi.nlm.nih.gov/pubmed/34599863
http://dx.doi.org/10.1002/cam4.4178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525092/
https://www.ncbi.nlm.nih.gov/pubmed/34599863
http://dx.doi.org/10.1002/cam4.4178

Ejemplares similares